Pacific Biosciences of California · NASDAQ: PACB · Medical Devices
Over the past week, Pacific Biosciences of California (PACB) logged about 32 mentions across Reddit, X and news, and the read is an Adanos Sell. The crowd averages 28% bullish but is deeply split: Reddit runs 40% bullish while X sits at just 7%. Wall Street is more constructive, with 4 of 8 analysts rating PACB a buy.
There is little buzz around PACB this week and little agreement on direction, which is why it reads as a Sell.
Wall Street’s 50% buy share sits next to a crowd that ranges from X at 7% to Reddit at 40%. No other tracker puts the two side by side.
Across 8 analysts the consensus is a Buy: 4 buy calls against 1 sell, with an average 12-month price target of $2.16.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is improving and the 3 sources disagree sharply, so the read is a Sell.
Analysts sit 22 points above the crowd average of 28%, the professionals are more constructive than retail. The split is inside the crowd: Reddit reads 40% bullish while X sits at 7%, a 33-point spread that single-source trackers miss.
Over the 30-day window, Pacific Biosciences of California (PACB) buzz held subdued around 30.7 while the price drifted up 88.1% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 13.4M shares. Updated Oct 03, 2026. Over the last 7 trading days, PACB gained 60.8%. Buzz activity in the recent week averaged 32.0 and was relatively stable, swinging between 27.4 and 36.8. Recent volume is running above the 30-day average, suggesting heightened trading interest. Daily crowd sentiment leaned bullish on 4 of the 10 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for PACB and 2110+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live PACB sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Oct 03, 2026.
| Adanos signal | Sell |
|---|---|
| Analyst consensus | Buy (4 / 3 / 1) |
| Crowd bullish (7d) | 28% |
| Avg price target | $2.16 |
| Most bullish source | Reddit, 40% |
| Most bearish source | X, 7% |
| Sentiment spread | 33 pts |
| Mentions (7d) | 32 |
| Market cap | $780.2M |
| EPS · Beta | -$0.44 · 2.3 |
| Revenue (TTM) | $159.3M · -82% margin |
| Industry | Medical Devices |
Based on aggregated sentiment from Reddit, X and News sources, Pacific Biosciences of California (PACB) currently carries an Adanos sell signal with 93/100 conviction. The current cross-source average reads 28% bullish across 3 active sources. Those sources contribute 32 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Pacific Biosciences of California (PACB) is fairly quiet with 10 mentions over the last 7 days; the 30-day context spans 3 tracked subreddits. The 7-day tone is 40% bullish; 3-day activity momentum is rising, suggesting building attention.
The crowd reads bearish on Pacific Biosciences of California (PACB), averaging 28% bullish across 3 tracked sources over the last 7 days. The two ends of the range are Reddit at 40% bullish and X at 7%, a 33-point spread. On the professional side, 4 of 8 analysts rate PACB a buy.
Of the 8 analysts covering Pacific Biosciences of California (PACB), 4 rate it a buy, 3 a hold and 1 a sell, for a buy consensus. The average price target is $2.16. That puts the street ahead of the crowd, which averages 28% bullish.
Pacific Biosciences of California (PACB)'s cross-source average is bearish at 28% bullish. All 3 tracked sources lean bearish. Reddit reads 40% bullish, News reads 37% bullish and x coverage is the most negative at 7% bullish. The combined signal points to broad sell-side pressure with 93/100 conviction.
The cross-source average is bearish for Pacific Biosciences of California (PACB) at 28% bullish. All 3 tracked sources lean bearish. The most bearish reading is x at 7% bullish. 3-day activity momentum is falling on News, while reddit and x activity is rising. The sell signal carries 93/100 conviction.
X is the dominant discussion channel with 14 mentions (44% of total volume). Reddit contributes 10 mentions and News contributes 8 mentions. The cross-source average is bearish at 28% bullish, while reddit and x show rising 3-day activity. All 3 tracked sources lean bearish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. PACB's sell signal at 93/100 conviction reflects a bearish cross-source average at 28% bullish. All 3 tracked sources lean bearish. It is a research shortcut, not financial advice.
The PACB sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Sell signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key